Two tests and one reference [General Sta­tis­tics]

posted by ElMaestro  – Denmark, 2020-08-31 12:23 (1505 d 02:18 ago) – Posting: # 21896
Views: 7,826

Hi Brus,

❝ If one test and two references of different regions are tested in a bioequivalence study, is it necessary a α adjustment?

❝

❝ In my case, we want to demonstrate if the test product is bioequivalent to R1 (European product reference) or if test product is bioequivalent to R2 (Reference product in the United Kingdom).

❝

❝ If I have not misunderstood, in this case, alpha should be penalized, even if they are from different regions and to market in different regions because of the word "OR"?

❝

❝ Is there a way to not penalize alpha? If the "O" is changed to "AND"? Executing two different clinical trials (one for Europe and one for the UK)?


Here's a different way to look at it:
Can the same patient(s) be affected by your two tests? If yes, it is safer to use correction. If no, no correction should be necessary.
—
Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,253 posts in 4,886 threads, 1,668 registered users;
71 visitors (0 registered, 71 guests [including 13 identified bots]).
Forum time: 14:42 CEST (Europe/Vienna)

If you want a new idea, read an old book.    Ivan Pavlov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5